Literature DB >> 12664125

Magnetic resonance angiography of the peripheral arteries: current status.

James F M Meaney1.   

Abstract

Comprehensive imaging of the peripheral vasculature has traditionally only been possible with catheter angiography. With the introduction of time-of-flight magnetic resonance angiography (TOF MRA), non-invasive imaging of the peripheral arteries became a clinical reality; however, widespread adoption of TOF MRA did not occur due to long scan times and artefacts which precluded its use as a screening tool. Contrast-enhanced MRA, an extremely time-efficient technique with minimal associated artefacts, addresses most of the limitations of non-contrast techniques. Numerous technological advances, including bolus detection, optimized 3D volume placement, improved k-space filling mechanisms and the evolution from single-station to multi-location moving-table contrast-enhanced MRA, have facilitated the development of non-invasive evaluation of the peripheral vascular tree with contrast-enhanced techniques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12664125     DOI: 10.1007/s00330-002-1649-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Dose optimization of contrast-enhanced carotid MR angiography.

Authors:  M Unterweger; J M Froehlich; R A Kubik-Huch; B Seifert; M Birrer; T Huber; R Otto
Journal:  Eur Radiol       Date:  2005-05-05       Impact factor: 5.315

2.  Assessing the appropriateness and increasing the yield of renal angiography in patients undergoing coronary angiography: a scoring system.

Authors:  Gianluca Rigatelli; Giorgio Rigatelli
Journal:  Int J Cardiovasc Imaging       Date:  2005-07-14       Impact factor: 2.357

3.  Comprehensive MR angiography of the lower limbs: a hybrid dual-bolus approach including the pedal arteries.

Authors:  R Schmitt; G Coblenz; O Cherevatyy; H Brunner; S Fröhner; E Wedell; G Karg; G Christopoulos
Journal:  Eur Radiol       Date:  2005-07-22       Impact factor: 5.315

4.  High resolution 3 Tesla contrast-enhanced MR angiography of the hands in Raynaud's disease.

Authors:  J Walcher; R Strecker; S Goldacker; J Winterer; M Langer; T A Bley
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

Review 5.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

6.  Rapid High-resolution, Self-registered, Dual Lumen-contrast MRI Method for Vessel-wall Assessment in Peripheral Artery Disease:: A Preliminary Investigation.

Authors:  Michael C Langham; Benoit Desjardins; Erin K Englund; Emile R Mohler; Thomas F Floyd; Felix W Wehrli
Journal:  Acad Radiol       Date:  2016-02-22       Impact factor: 3.173

7.  MRI after implantation of a novel femoral closure device following intra-arterial catheterisation: implications for subsequent contrast-enhanced MR angiography.

Authors:  Oliver K Mohrs; Steffen E Petersen; Bernd Nowak; Hans-Ulrich Kauczor; Thomas Voigtlaender
Journal:  Eur Radiol       Date:  2009-11-21       Impact factor: 5.315

8.  Diagnostic accuracy of colour Doppler ultrasonography, CT angiography and blood-pool-enhanced MR angiography in assessing carotid stenosis: a comparative study with DSA in 170 patients.

Authors:  M Anzidei; A Napoli; F Zaccagna; P Di Paolo; L Saba; B Cavallo Marincola; C Zini; G Cartocci; L Di Mare; C Catalano; R Passariello
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

9.  Highly undersampled peripheral Time-of-Flight magnetic resonance angiography: optimized data acquisition and iterative image reconstruction.

Authors:  Jana Hutter; Robert Grimm; Christoph Forman; Joachim Hornegger; Peter Schmitt
Journal:  MAGMA       Date:  2015-01-22       Impact factor: 2.310

Review 10.  Current techniques for assessment of upper extremity vasculature prior to hemodialysis vascular access creation.

Authors:  R N Planken; J H M Tordoir; L E M Duijm; M W de Haan; T Leiner
Journal:  Eur Radiol       Date:  2007-05-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.